• InspireMD director Paul Stuka disclosed open-market purchases totaling 75,626 common shares at weighted average prices of $1.16 and $1.19.
• Directly held common shares rose to 632,871.
• Indirect holdings through Osiris were reported at 423,704 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InspireMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-022564), on May 12, 2026, and is solely responsible for the information contained therein.